Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Chunying, Hou"'
Publikováno v:
Journal of Traditional Chinese Medical Sciences, Vol 8, Iss 1, Pp 72-81 (2021)
Objective: To explore the potential biological mechanism of chronic obstructive pulmonary disease (COPD) qi deficiency syndrome, we used the integrated pharmacology network computing platform and carried out experimental verification. Methods: Using
Externí odkaz:
https://doaj.org/article/b7378ab6ba2840fc9754f8737defe999
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2022)
In recent years, the incidence of breast cancer has been increasing on an annual basis. Human epidermal growth factor receptor-2 (HER-2) is overexpressed in 15-20% human breast cancers, which is associated with poor prognosis and a high recurrence ra
Externí odkaz:
https://doaj.org/article/547dec31b57b4983bbe31b76f798e0d6
Autor:
Ran Xu, Tianhua Liu, Ling Zuo, Dongqing Guo, Guancheng Ye, Jingjing Jiang, Xue Yu, Shujing Zhang, Chunying Hou
Publikováno v:
Biochemistry and Biophysics Reports, Vol 28, Iss , Pp 101122- (2021)
Therapies for lung adenocarcinoma (LUAD) are mainly limited by drug resistance, metastasis or recurrence related to cancer stem cells (CSCs) with high proliferation and self-renewing. This research validated that miR-31 was over-expressed in LUAD by
Externí odkaz:
https://doaj.org/article/18ad2abe1e7f4249b6e29b3e99c5cb77
Autor:
Hewei, Zhang, Shuran, Ma, Tian, Tian, Ya, Xu, Dandan, Zhao, Tong, Wang, Chunying, Hou, Shujing, Zhang
Publikováno v:
In Journal of Traditional Chinese Medicine April 2018 38(2):211-217
Publikováno v:
Journal of Traditional Chinese Medical Sciences, Vol 8, Iss 1, Pp 72-81 (2021)
Objective: To explore the potential biological mechanism of chronic obstructive pulmonary disease (COPD) qi deficiency syndrome, we used the integrated pharmacology network computing platform and carried out experimental verification. Methods: Using
Publikováno v:
Frontiers of medicine. 16(3)
The discovery of immune checkpoint inhibitors, such as PD-1/PD-L1 and CTLA-4, has played an important role in the development of cancer immunotherapy. However, immune-related adverse events often occur because of the enhanced immune response enabled
Autor:
Tianhua, Liu, Jian, Guo, Tongxin, Wang, Shuofeng, Zhang, Xue, Yu, Chunying, Hou, Dongqing, Guo
Publikováno v:
Discovery medicine. 28(153)
As an important derivative of the herb medicine Artemisia annua L., dihydroartemisinin (DHA) exhibits anti-hepatocellular carcinoma (HCC) activities. However, the underlying molecular mechanism is still unclear. In the present study, the network phar
Autor:
Xinzhen Guo, Chunying Hou, Jie Zhang, Yang Zhong, Shiqian Zhang, Ming Shao, Guojun Li, Zhenggang Bi, Baoxin Li
Publikováno v:
International Journal of Molecular Medicine. 38:919-926
The objective of the present study was to explore the molecular mechanism with which a single nucleotide polymorphism (rs61764370) interferes with the interaction between the 3'-untranslated region (3'-UTR) of Kirsten rat sarcoma viral oncogene homol
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 126, Iss, Pp 109862-(2020)
Hepatocellular carcinoma (HCC), as the major primary liver cancer, is one of the most prevalent malignant diseases with a high mortality rate worldwide. Prior studies have demonstrated that dihydroartemisinin (DHA), the semisynthetic derivative of ar
Autor:
Chenglin Yang, Chunying Hou, Hepeng Zhang, Dewei Wang, Yan Ma, Yunqi Zhang, Xiaoyan Xu, Zhenggang Bi, Shuo Geng, International Journal of Molecular Sciences Editorial Office
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 11, p 3541 (2018)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Osteosarcoma (OS) is the most common malignant bone tumor in children and young adults, the early symptoms and signs of which are non-specific. The discovery of microRNAs (miRNAs) provides a new avenue for the early diagnosis and treatment of OS. miR